Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Jobs set to go and cancer treatments slashed in tough federal research cuts

ImmVirX says the changes would cut funding by more than $6 million a year and force staff and trial reductions.

Summary by Newcastle Herald
Newcastle biotech ImmVirX faces a $6 million R&D loss from Albanese government cuts. Darren Shafren comments on how this affects cancer immunotherapy patients.

2 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Newcastle Herald broke the news in Newcastle, Australia on Tuesday, August 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal